ABSTRACT

Fentanyl Analogues: Prespectives on Classwide Scheduling, Hearing Before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Sixteenth Congress, Second Session, January 28, 2020   [open pdf - 8MB]

Alternate Title: Fentanyl Analogues: Perspectives on Classwide Scheduling, Hearing Before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Sixteenth Congress, Second Session, January 28, 2020

This is the January 28, 2020 hearing on "Fentanyl Analogues: Prespectives [sic] on Classwide Scheduling," held before the U.S. House Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary. From the opening statement of Karen Bass: "Our country faces an opioid crisis, including incidences of overdoses involving fentanyl and fentanyl analogues. By some measures, more than 40 percent of heroin-related deaths in recent years involve some level of fentanyl. In 2017, a drug overdose crisis tragically claimed the lives of over 70,000 of our fellow Americans. Many died from overdoses. In a disturbing trend, illicit drug manufacturers, particularly in places like China, have found ways to change the composition of fentanyl-related substances to avoid or postpone the control and prosecution of these substances in the United States. Because of these dangers, 2 years ago, the DEA [U.S. Drug Enforcement Agency] placed fentanyl analogues temporarily on Schedule 1 of the Controlled Substances Act, an administrative action that will expire February 6th." Statements, letters, and materials submitted for the record include those of the following: Brett P. Giroir, Amanda Liskamm, Sandra D. Comer, Kevin L. Butler, Donald A. Holman, and Daniel Ciccarone.

Report Number:
Serial No. 116-71
Publisher:
Date:
2021
Copyright:
Public Domain
Retrieved From:
U. S. Government Publishing Office: http://www.gpo.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations